All Releases
 |
Sigma-Aldrich Launches 'What's Your Favorite Gene?' Application On Facebook(R) Platform
Nov 18, 2009
|
10.5 KB |
|
| |
ST. LOUIS, Nov 18, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich(R) (Nasdaq: SIAL) today announced the launch of a unique life science-focused application for the social media site, Facebook. Developed and marketed by Sigma(R) Life Science, the 'What's Your Favorite Gene?' application is the first and currently only applicati...
|
|
Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
Nov 10, 2009
|
7.0 KB |
|
| |
ST. LOUIS, Nov 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- At the Board of Directors meeting held today, the Directors declared a quarterly cash dividend of $.145 per share, an 11.5% increase over the prior year level. The dividend is payable on December 15, 2009 to shareholders of record on December 1, 2009.
About Sigma-Aldrich: Si...
|
|
Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
Nov 10, 2009
|
11.4 KB |
|
| |
ST. LOUIS, Nov 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich(R) (Nasdaq: SIAL) today announced that it has entered into an exclusive worldwide distribution agreement with Stemgent, Inc. to offer Stemgent's portfolio of lentivirus-based delivery systems for the generation of induced pluripotent stem (iPS) cells. This agree...
|
|
Sigma-Aldrich Signs License Agreement With Polyplus-transfection to Offer Novel ZNA™ Oligonucleotides
Nov 3, 2009
|
10.5 KB |
|
| |
ST. LOUIS, Nov 03, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich (Nasdaq: SIAL) today announced a worldwide licensing agreement with Polyplus-transfection (Strasbourg, France) to manufacture and commercialize Zip Nucleic Acid (ZNA(TM)*) oligonucleotides, a new technology that providessolutions for increased affinity for nucle...
|
|
Sigma-Aldrich® Teams With 3M to Provide TIPS Pentacene Organic Electronics Semiconductor for Growing Printed Electronics Industry
Oct 29, 2009
|
11.6 KB |
|
| |
ST. LOUIS, Oct 29, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich (Nasdaq: SIAL) announced today it has teamed with 3M to distribute TIPS Pentacene, a high-performance soluble organic semiconductor for printed and flexible electronics. Sigma-Aldrich will exclusively distribute research quantities of TIPS Pentacene globally thr...
|
|
Sigma-Aldrich (Nasdaq: SIAL) Reports 9.4% Increase in Q3 2009 Diluted EPS; Sales Performance Improved in Q3 2009 Over Earlier 2009 Quarters. Full Year 2009 Diluted EPS Expected to Exceed $2.70.
Oct 22, 2009
|
28.2 KB |
|
| |
ST. LOUIS, Oct 22, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- HIGHLIGHTS (all percentages are to comparable periods in 2008):2009 Results
-- Q3 2009 reported sales declined by 1.3%; excluding the impact of
currency, sales grew organically by 2.3% from a year ago, driven by
improved sales of Research Biotech produ...
|
|
Sigma-Aldrich Announces SAGE(TM) Priority Partners Program; Seeks Researchers to Evaluate New Knockout Rat Models
Oct 20, 2009
|
10.9 KB |
|
| |
ST. LOUIS, Oct 20, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich(R) (Nasdaq: SIAL) today announced the launch of the SAGE(TM) Priority Partners Program, through which the Company plans to build a network of researchers to evaluate the 'knockout' rat models it is developing to support pre-clinical research work across a number...
|
|
Sigma-Aldrich Announces SAGEspeed(TM) Custom Model Program for Expedient Creation of Genetically-Engineered Rodent Research Models
Oct 19, 2009
|
9.5 KB |
|
| |
ST. LOUIS, Oct 19, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich(R) (Nasdaq: SIAL) today announced the launch of SAGEspeed(TM), a program to develop human disease models in rodents using its proprietary novel CompoZr(TM) Zinc Finger Nuclease (ZFN) gene editing technology (http://www.compozrzfn.com). This program will provide...
|
|
SAFC Pharma(R) Announces Completion of $12M Contract Manufacturing Facility Expansion in Carlsbad, Calif.
Oct 13, 2009
|
12.7 KB |
|
| |
ST. LOUIS, Oct 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- SAFC Pharma(R), a business segment of SAFC(R), a member of the Sigma-Aldrich(R) Group (Nasdaq: SIAL), today announced the completion of an addition to its Carlsbad, Calif., facility that expands the Company's contract manufacturing services for its late phase and commercial c...
|
|
SAFC Pharma Installs the Industry's First Commercial Dual Wavelength X-Ray Diffractometer
Oct 13, 2009
|
11.7 KB |
|
| |
ST. LOUIS and MADRID, Oct 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- CPhI -- SAFC Pharma(R), a business segment of SAFC(R), a member of the Sigma-Aldrich(R) Group (Nasdaq: SIAL), today announced that its Pharmorphix(R) Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. T...
|
|
Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
Oct 6, 2009
|
10.1 KB |
|
| |
ST. LOUIS, Oct 06, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich (Nasdaq: SIAL) announced today that it has signed a distribution agreement with ThalesNano, the world leader in bench top flow chemistry instruments, the terms of which will see Sigma-Aldrich distribute ThalesNano's complete line of approximately 400 CatCart(R) ...
|
|
Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement
Oct 5, 2009
|
12.9 KB |
|
| |
ST. LOUIS and RICHMOND, Calif., Oct 05, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-mod...
|
|
Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
Oct 1, 2009
|
8.3 KB |
|
| |
ST. LOUIS, Oct 01, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich (Nasdaq: SIAL) is pleased to announce the appointment of George Miller as Sr. Vice President, General Counsel and Secretary. In his new role, Miller will join the company's executive management team and manage its legal services and corporate governance processe...
|
|
Sigma-Aldrich Corporation Announces 3rd Quarter 2009 Conference Call
Oct 1, 2009
|
9.4 KB |
|
| |
ST. LOUIS, Oct 1, 2009 (GlobeNewswire via COMTEX News Network) -- Sigma-Aldrich Corporation (Nasdaq:SIAL) will hold its quarterly conference call to discuss third quarter results on Thursday, October 22, 2009 at 11:00 AM Eastern Time (10:00 AM Central Time).
Date: October 22, 2009
Time: 10:00 AM CT
Toll Free: ...
|
|
Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinson's Disease Research Models
Oct 1, 2009
|
11.5 KB |
|
| |
NEW YORK and ST. LOUIS, Oct 01, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich (Nasdaq: SIAL) and The Michael J. Fox Foundation (MJFF) today announced a collaboration that is expected to develop more accurate preclinical research models of Parkinson's disease, a neurodegenerative disorder of unknown cause that affects nearly f...
|
|
Sigma-Aldrich to Present at the UBS Global Life Sciences Conference on Monday, September 21, 2009
Sep 15, 2009
|
7.5 KB |
|
| |
ST. LOUIS, Sept 15, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) will be presenting at the UBS Global Life Sciences Conference on Monday, September 21st at 8:30 AM Eastern Daylight Time in New York, NY. Interested parties may listen via live audio broadcast over the Internet available at http://inv...
|
|
Sigma-Aldrich to Present at the Thomas Weisel Healthcare Conference on Thursday, September 10, 2009
Sep 3, 2009
|
7.6 KB |
|
| |
ST. LOUIS, Sept 03, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) will be presenting at the Thomas Weisel Healthcare Conference on Thursday, September 10th at 1:30 PM Eastern Daylight Time in Boston, MA. Interested parties may listen via live audio broadcast over the Internet available at http://inv...
|
|
New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene-Editing Technology
Aug 21, 2009
|
9.8 KB |
|
| |
ST. LOUIS, Aug 21, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich(R) (Nasdaq: SIAL) announced today that scientists at its new Sigma Advanced Genetic Engineering (SAGE(TM)) Labs in St. Louis will leverage its exclusive CompoZr(TM) Zinc Finger Nuclease (ZFN) gene editing technology (www.compozrzfn.com) to define, develop and of...
|
|
Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
Aug 13, 2009
|
9.2 KB |
|
| |
ST. LOUIS, Aug 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich (Nasdaq: SIAL) announced today that its chemistry review journal, Aldrichimica Acta, was recently ranked number one by Impact Factor (IF) when evaluated against all 55 international journals in the field of Organic Chemistry.
"We are excited about this latest r...
|
|
Sigma-Aldrich Offers Customizable Synthetic Extracellular Matrix for Stem Cell Research
Aug 13, 2009
|
9.9 KB |
|
| |
ST. LOUIS, Mo., Aug 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Sigma-Aldrich(R) (Nasdaq: SIAL) today announced an agreement with Glycosan BioSystems for the sale of HyStem(TM), a fully customizable synthetic extracellular matrix (ECM) for stem cell research. HyStem offers researchers flexibility to tailor microenvironments for their...
|
|
|
= add release to Briefcase
